1. School of Pharmacy, Anhui Medical University, Hefei 230032, China 2. Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei 230027, China 3. Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
γδ T cells display unique developmental, distributional, and functional patterns and can rapidly respond to various insults and contribute to diverse diseases. Different subtypes of γδ T cells are produced in the thymus prior to their migration to peripheral tissues. γδ T cells are enriched in the liver and exhibit liver-specific features. Accumulating evidence reveals that γδ T cells play important roles in liver infection, non-alcoholic fatty liver disease, autoimmune hepatitis, liver fibrosis and cirrhosis, and liver cancer and regeneration. In this study, we review the properties of hepatic γδ T cells and summarize the roles of γδ T cells in liver diseases. We believe that determining the properties and functions of γδ T cells in liver diseases enhances our understanding of the pathogenesis of liver diseases and is useful for the design of novel γδ T cell-based therapeutic regimens for liver diseases.
Godfrey DI, Kennedy J, Suda T, Zlotnik A. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3−CD4−CD8− triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 1993; 150(10): 4244–4252
pmid: 8387091
Ciofani M, Knowles GC, Wiest DL, von Boehmer H, Zúñiga-Pflücker JC. Stage-specific and differential notch dependency at the alphabeta and γδ T lineage bifurcation. Immunity 2006; 25(1): 105–116 https://doi.org/10.1016/j.immuni.2006.05.010
pmid: 16814577
4
Hoh A, Dewerth A, Vogt F, Wenz J, Baeuerle PA, Warmann SW, Fuchs J, Armeanu-Ebinger S. The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture. Liver Int 2013; 33(1):127–136 https://doi.org/10.1111/liv.12011
pmid: 23088518
5
Haas JD, González FH, Schmitz S, Chennupati V, Föhse L, Kremmer E, Förster R, Prinz I. CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-producing γδ effector T cells. Eur J Immunol 2009; 39(12): 3488–3497 https://doi.org/10.1002/eji.200939922
pmid: 19830744
6
Muñoz-Ruiz M, Sumaria N, Pennington DJ, Silva-Santos B. Thymic determinants of gd T cell differentiation. Trends Immunol 2017; 38(5): 336–344 https://doi.org/10.1016/j.it.2017.01.007
pmid: 28285814
7
Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 1998; 279(5357): 1737–1740 https://doi.org/10.1126/science.279.5357.1737
pmid: 9497295
Vantourout P, Hayday A. Six-of-the-best: unique contributions of gd T cells to immunology. Nat Rev Immunol 2013; 13(2): 88–100 https://doi.org/10.1038/nri3384
pmid: 23348415
10
Rajoriya N, Fergusson JR, Leithead JA, Klenerman P. γδ T-lymphocytes in hepatitis C and chronic liver disease. Front Immunol 2014; 5: 400 https://doi.org/10.3389/fimmu.2014.00400
pmid: 25206355
11
Wang X, Sun R, Wei H, Tian Z. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of gd T cells with macrophages. Hepatology 2013; 57(1): 373–384 https://doi.org/10.1002/hep.25982
pmid: 22821628
12
Protzer U, Maini MK, Knolle PA. Living in the liver: hepatic infections. Nat Rev Immunol 2012; 12(3): 201–213 https://doi.org/10.1038/nri3169
pmid: 22362353
13
Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 2014; 14(3): 181–194 https://doi.org/10.1038/nri3623
pmid: 24566915
14
Robinson MW, Harmon C, O’Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol 2016; 13(3): 267–276 https://doi.org/10.1038/cmi.2016.3
pmid: 27063467
15
Shuai Z, Leung MW, He X, Zhang W, Yang G, Leung PS, Eric Gershwin M. Adaptive immunity in the liver. Cell Mol Immunol 2016; 13(3): 354–368 https://doi.org/10.1038/cmi.2016.4
pmid: 26996069
16
Horst AK, Neumann K, Diehl L, Tiegs G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell Mol Immunol 2016; 13(3): 277–292 https://doi.org/10.1038/cmi.2015.112
pmid: 27041638
Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol 2016; 13(3): 337–346 https://doi.org/10.1038/cmi.2015.115
pmid: 26972772
20
Peng H, Wisse E, Tian Z. Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol 2016; 13(3): 328–336 https://doi.org/10.1038/cmi.2015.96
pmid: 26639736
21
Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol 2016; 13(3): 316–327 https://doi.org/10.1038/cmi.2015.104
pmid: 26908374
Bonneville M, O’Brien RL, Born WK. γδ T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10(7): 467–478 https://doi.org/10.1038/nri2781
pmid: 20539306
24
Rao R, Graffeo CS, Gulati R, Jamal M, Narayan S, Zambirinis CP, Barilla R, Deutsch M, Greco SH, Ochi A, Tomkötter L, Blobstein R, Avanzi A, Tippens DM, Gelbstein Y, Van Heerden E, Miller G. Interleukin 17-producing γδ. T cells promote hepatic regeneration in mice. Gastroenterology 2014; 147(2):473–84.e2 https://doi.org/10.1053/j.gastro.2014.04.042
pmid: 24801349
25
Li F, Hao X, Chen Y, Bai L, Gao X, Lian Z, Wei H, Sun R, Tian Z. The microbiota maintain homeostasis of liver-resident gdT-17 cells in a lipid antigen/CD1d-dependent manner. Nat Commun 2017; 7: 13839 https://doi.org/10.1038/ncomms13839
pmid: 28067223
Chen M, Zhang D, Zhen W, Shi Q, Liu Y, Ling N, Peng M, Tang K, Hu P, Hu H, Ren H. Characteristics of circulating T cell receptor gd T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(d)2 subtype and chronic HBV infection. J Infect Dis 2008; 198(11): 1643–1650 https://doi.org/10.1086/593065
pmid: 18954265
29
Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, Zhang D, Ren H. Enhanced functions of peripheral gd T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro. PLoS One 2015; 10(3): e0120086 https://doi.org/10.1371/journal.pone.0120086
pmid: 25774808
30
Chen M, Hu P, Peng H, Zeng W, Shi X, Lei Y, Hu H, Zhang D, Ren H. Enhanced peripheral gd T cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression. J Clin Immunol 2012; 32(4): 877–885 https://doi.org/10.1007/s10875-012-9678-z
pmid: 22415432
31
Kong X, Sun R, Chen Y, Wei H, Tian Z. γδ T cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. J Immunol 2014; 193(4): 1645–1653 https://doi.org/10.4049/jimmunol.1303432
pmid: 25015833
32
Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5(3): 215–229 https://doi.org/10.1038/nri1573
pmid: 15738952
33
Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, Hu H, Peng M, Hu P, Ren H, Tian Z, Zhang D. Functional dichotomy of Vd2 gd T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-g production. Sci Rep 2016; 6(1): 26296 https://doi.org/10.1038/srep26296
pmid: 27192960
34
Tseng CT, Miskovsky E, Houghton M, Klimpel GR. Characterization of liver T-cell receptor gd T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 2001; 33(5): 1312–1320 https://doi.org/10.1053/jhep.2001.24269
pmid: 11343261
35
Agrati C, Alonzi T, De Santis R, Castilletti C, Abbate I, Capobianchi MR, D’Offizi G, Siepi F, Fimia GM, Tripodi M, Poccia F. Activation of Vγ9Vδ2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication. Int Immunol 2006; 18(1): 11–18 https://doi.org/10.1093/intimm/dxh337
pmid: 16361319
36
Sardinha LR, Elias RM, Mosca T, Bastos KR, Marinho CR, D’Império Lima MR, Alvarez JM. Contribution of NK, NK T, γδ T, and αβ T cells to the γ interferon response required for liver protection against Trypanosoma cruzi. Infect Immun 2006; 74(4): 2031–2042 https://doi.org/10.1128/IAI.74.4.2031-2042.2006
pmid: 16552032
37
Tramonti D, Rhodes K, Martin N, Dalton JE, Andrew E, Carding SR. γδ T cell-mediated regulation of chemokine producing macrophages during Listeria monocytogenes infection-induced inflammation. J Pathol 2008; 216(2): 262–270 https://doi.org/10.1002/path.2412
pmid: 18767021
38
Chen D, Luo X, Xie H, Gao Z, Fang H, Huang J. Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver. Immunology 2013; 139(4): 523–532 https://doi.org/10.1111/imm.12105
pmid: 23551262
Harley IT, Stankiewicz TE, Giles DA, Softic S, Flick LM, Cappelletti M, Sheridan R, Xanthakos SA, Steinbrecher KA, Sartor RB, Kohli R, Karp CL, Divanovic S. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology 2014; 59(5): 1830–1839 https://doi.org/10.1002/hep.26746
pmid: 24115079
41
Xu R, Tao A, Zhang S, Zhang M. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Acta Biochim Biophys Sin (Shanghai) 2013; 45(9): 726–733 https://doi.org/10.1093/abbs/gmt065
pmid: 23786840
Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of gd T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 1996; 23(5): 988–993
pmid: 8621180
46
Hua F, Wang L, Rong X, Hu Y, Zhang JM, He W, Zhang FC. Elevation of Vd1 T cells in peripheral blood and livers of patients with primary biliary cholangitis. Clin Exp Immunol 2016; 186(3): 347–355 https://doi.org/10.1111/cei.12852
pmid: 27543908
47
Wen L, Peakman M, Mieli-Vergani G, Vergani D. Elevation of activated gd T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease. Clin Exp Immunol 1992; 89(1): 78–82 https://doi.org/10.1111/j.1365-2249.1992.tb06881.x
pmid: 1385768
48
Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, Hussain MJ, Ma Y, Lenzi M, Mieli-Vergani G, Bianchi FB, Vergani D, Muratori L. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52(3): 999–1007 https://doi.org/10.1002/hep.23792
pmid: 20683931
49
Nishio K, Miyagi T, Tatsumi T, Mukai K, Yokoyama Y, Yoshioka T, Sakamori R, Hikita H, Kodama T, Shimizu S, Shigekawa M, Nawa T, Yoshihara H, Hiramatsu N, Yamanaka H, Seino K, Takehara T. Invariant natural killer T cell deficiency leads to the development of spontaneous liver inflammation dependent on gd T cells in mice. J Gastroenterol 2015; 50(11): 1124–1133 https://doi.org/10.1007/s00535-015-1060-5
pmid: 25791517
50
Zhang H, Bernuzzi F, Lleo A, Ma X, Invernizzi P. Therapeutic potential of IL-17-mediated signaling pathway in autoimmune liver diseases. Mediators Inflamm 2015; 2015: 436450 https://doi.org/10.1155/2015/436450
pmid: 26146463
51
Ujiie H, Shevach EM. γδ T cells protect the liver and lungs of mice from autoimmunity induced by scurfy lymphocytes. J Immunol 2016; 196(4): 1517–1528 https://doi.org/10.4049/jimmunol.1501774
pmid: 26773142
52
Zhao N, Hao J, Ni Y, Luo W, Liang R, Cao G, Zhao Y, Wang P, Zhao L, Tian Z, Flavell R, Hong Z, Han J, Yao Z, Wu Z, Yin Z. Vg4 gd T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J Immunol 2011; 187(10): 5007–5014 https://doi.org/10.4049/jimmunol.1101315
pmid: 21987663
53
Hammerich L, Bangen JM, Govaere O, Zimmermann HW, Gassler N, Huss S, Liedtke C, Prinz I, Lira SA, Luedde T, Roskams T, Trautwein C, Heymann F, Tacke F. Chemokine receptor CCR6-dependent accumulation of gd T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 2014; 59(2): 630–642 https://doi.org/10.1002/hep.26697
pmid: 23959575
54
Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH, Jang MJ, Jo E, Kim SC, Han YM, Park KG, Jeong WI. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by gd T cells in liver fibrosis. Hepatology 2016; 64(2): 616–631 https://doi.org/10.1002/hep.28644
pmid: 27178735
55
Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M, Österreicher CH, Stickel F, Ley K, Brenner DA, Kisseleva T. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012; 143(3):765–776.e3 https://doi.org/10.1053/j.gastro.2012.05.049
pmid: 22687286
56
Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C, Wang X, Ryffel B, Sun B. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013; 191(4): 1835–1844 https://doi.org/10.4049/jimmunol.1203013
pmid: 23842754
57
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66(2): 115–132 https://doi.org/10.3322/caac.21338
pmid: 26808342
58
Yi Y, He HW, Wang JX, Cai XY, Li YW, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. The functional impairment of HCC-infiltrating gd T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner. J Hepatol 2013; 58(5): 977–983 https://doi.org/10.1016/j.jhep.2012.12.015
pmid: 23262246
59
Cai XY, Wang JX, Yi Y, He HW, Ni XC, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Low counts of γδ T cells in peritumoral liver tissue are related to more frequent recurrence in patients with hepatocellular carcinoma after curative resection. Asian Pac J Cancer Prev 2014; 15(2): 775–780
pmid: 24568494
60
Ma S, Cheng Q, Cai Y, Gong H, Wu Y, Yu X, Shi L, Wu D, Dong C, Liu H. IL-17A produced by gd T cells promotes tumor growth in hepatocellular carcinoma. Cancer Res 2014; 74(7): 1969–1982 https://doi.org/10.1158/0008-5472.CAN-13-2534
pmid: 24525743
Wu D, Wu P, Qiu F, Wei Q, Huang J. Human gd T-cell subsets and their involvement in tumor immunity. Cell Mol Immunol 2017; 14(3): 245–253 https://doi.org/10.1038/cmi.2016.55
pmid: 27890919
64
Toutirais O, Cabillic F, Le Friec G, Salot S, Loyer P, Le Gallo M, Desille M, de La Pintière CT, Daniel P, Bouet F, Catros V. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vg9Vd2 T cells. Eur J Immunol 2009; 39(5): 1361–1368 https://doi.org/10.1002/eji.200838409
pmid: 19404979
65
Sugai S, Yoshikawa T, Iwama T, Tsuchiya N, Ueda N, Fujinami N, Shimomura M, Zhang R, Kaneko S, Uemura Y, Nakatsura T. Hepatocellular carcinoma cell sensitivity to Vg9Vd2 T lymphocyte-mediated killing is increased by zoledronate. Int J Oncol 2016; 48(5): 1794–1804 https://doi.org/10.3892/ijo.2016.3403
pmid: 26936487
Furuya S, Kono H, Hara M, Hirayama K, Tsuchiya M, Fujii H. Interleukin-17A plays a pivotal role after partial hepatectomy in mice. J Surg Res 2013; 184(2): 838–846 https://doi.org/10.1016/j.jss.2013.03.033
pmid: 23590864
68
Wu X, Sun R, Chen Y, Zheng X, Bai L, Lian Z, Wei H, Tian Z. Oral ampicillin inhibits liver regeneration by breaking hepatic innate immune tolerance normally maintained by gut commensal bacteria. Hepatology 2015; 62(1): 253–264 https://doi.org/10.1002/hep.27791
pmid: 25783863
69
Wu YL, Ding YP, Tanaka Y, Shen LW, Wei CH, Minato N, Zhang W. γδ T cells and their potential for immunotherapy. Int J Biol Sci 2014; 10(2): 119–135 https://doi.org/10.7150/ijbs.7823
pmid: 24520210
70
Legut M, Cole DK, Sewell AK. The promise of gd T cells and the gd T cell receptor for cancer immunotherapy. Cell Mol Immunol 2015; 12(6): 656–668 https://doi.org/10.1038/cmi.2015.28
pmid: 25864915